Induction of poly(ADP-ribose) polymerase-1 cleavage by antitumor triptycene bisquinones in wild-type and daunorubicin-resistant HL-60 cell lines

Cancer Letters

Volumn 188, Issue 1-2, 2002, Pages 73-83

  Wang, Yang ^a   Perchellet, Elisabeth M ^a   Tamura, Masafumi ^a   Hua, Duy H ^a   Perchellet, Jean Pierre ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Poly(ADP ribose) polymerase 1 cleavage; Sensitive and multidrug resistant HL 60 cells; Triptycene bisquinones

Indexed keywords

ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CELL MARKER; DAUNORUBICIN; DNA FRAGMENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; QUINONE DERIVATIVE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRIPTYCENE DERIVATIVE; TT 0; TT 13; TT 16; TT 19; TT 2; TT 21; TT 24; TT 3; TT 5; TT 7; TT 8; TT 9; TT24; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG SCREENING; DRUG SENSITIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN SYNTHESIS; RNA SYNTHESIS; WILD TYPE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL SURVIVAL; DAUNORUBICIN; DNA, NEOPLASM; DRUG RESISTANCE, NEOPLASM; ENZYME INDUCTION; HL-60 CELLS; HUMANS; POLY(ADP-RIBOSE) POLYMERASES; QUINONES;

EID: 0037114350     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00493-7     Document Type: Article

References (40)

1. Smets L.A. Programmed cell death (apoptosis) and response to anti-cancer drugs. Anti-Cancer Drugs. 5:1994;3-9.
2. Mesner P.W., Budihardjo I.I., Kaufmann S.H. Chemotherapy-induced apoptosis. Adv. Pharmacol. 41:1997;461-499.
3. Hannun Y.A. Apoptosis and the dilemma of cancer chemotherapy. Blood. 89:1997;1845-1853.
4. Debatin K.M. Activation of apoptosis pathways by anticancer treatment. Toxicol. Lett. 112-113:2000;41-48.
5. Lowe S.W., Lin A.W. Apoptosis in cancer. Carcinogenesis. 21:2000;485-495.
6. Kaufmann S.H., Earnshaw W.C. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256:2000;42-49.
7. Monks T.J., Hanzlik R.P., Cohen G.M., Ross D., Graham D.G. Quinone chemistry and toxicity. Toxicol. Appl. Pharmacol. 112:1992;2-16.
8. Myers C.E., Chabner B.A. Anthracyclines. Chabner B.A., Collins J.M., Cancer Chemotherapy: Principles and Practice. 1990;356-381 Lippincott, Philadelphia, PA.
9. Rossi L., Moore G.A., Orrenius S., O'Brien P.J. Quinone toxicity in hepatocytes without oxidative stress. Arch. Biochem. Biophys. 251:1986;25-35.
10. Begleiter A., Leith M.K., McClarty G., Beenken S., Goldenberg G.J., Wright J.A. Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agents. Cancer Res. 48:1988;1727-1735.
11. 2/M cell cycle arrest and apoptosis. Free Rad. Biol. Med. 24:1998;848-854.
12. Liu L.F. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 58:1989;351-375.
13. Mimnaugh E.G., Kennedy K.A., Trush M.A., Sinha B.K. Adriamycin-enhanced membrane lipid peroxidation in isolated rat nuclei. Cancer Res. 45:1985;3296-3304.
14. Ganapathi R., Grabowski D., Hoeltge G., Neelon R. Modulation of doxorubicin-induced chromosomal damage by calmodulin inhibitors and its relationship to cytotoxicity in progressively doxorubicin-resistant tumor cells. Biochem. Pharmacol. 40:1990;1657-1662.
15. Ling Y.H., Priebe W., Perez-Soler R. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res. 53:1993;1845-1852.
16. Ramachandran C., You W., Krishan A. Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells. Anticancer Res. 17:1997;3369-3376.
17. Skladanowski A., Konopa J. Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells. Biochem. Pharmacol. 46:1993;375-382.
18. Côme M.G., Skladanowski A., Larsen A.K., Laurent G. Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells. Br. J. Cancer. 79:1999;1090-1097.
19. Aszalos A., Ladányi A., Bocsi J., Szende B. Induction of apoptosis in MDR1 expressing cells by daunorubicin with combinations of suboptimal concentrations of P-glycoprotein modulators. Cancer Lett. 167:2001;157-162.
20. Gamen S., Anel A., Lasierra P., Alava M.A., Martinez-Lorenzo M.J., Piñeiro A., Naval J. Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way. FEBS Lett. 417:1997;360-364.
21. Perchellet E.M., Magill M.J., Huang X., Brantis C.E., Hua D.H., Perchellet J.P. Triptycenes: a novel synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, induce DNA cleavage and decrease the viability of leukemic cells in the nanomolar range in vitro. Anti-Cancer Drugs. 10:1999;749-766.
22. Perchellet E.M., Sperfslage B.J., Wang Y., Huang X., Tamura M., Hua D.H., Perchellet J.P. Among substituted 9,10-dihydro-9,10-[1,2]benzenoanthracene-1,4,5,8-tetraones, the lead antitumor triptycene bisquinone TT24 blocks nucleoside transport, induces apoptotic DNA fragmentation and decreases the viability of L1210 leukemic cells in the nanomolar range of daunorubicin in vitro. Anti-Cancer Drugs. 13:2002;. in press.
23. Wang B., Wu M., Perchellet E.M., McIlvain C.J., Sperfslage B.J., Huang X., Tamura M., Stephany H.A., Hua D.H., Perchellet J.P. A synthetic triptycene bisquinone, which blocks nucleoside transport and induces DNA fragmentation, retains its cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines. Int. J. Oncol. 19:2001;1169-1178.
24. Nagata S. Apoptotic DNA fragmentation. Exp. Cell Res. 256:2000;12-18.
25. Duriez P.J., Shah G.M. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem. Cell Biol. 75:1997;337-349.
26. Herceg Z., Wang Z.Q. Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death. Mutat. Res. 477:2001;97-110.
27. Bürkle A. Poly(APD-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability. Cancer Lett. 163:2001;1-5.
28. Kaufmann S.H., Desnoyers S., Ottaviano Y., Davidson N.E., Poirier G.G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53:1993;3976-3985.
29. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A., Munday N.A., Raju S.M., Smulson M.E., Yamin T.T., Yu V.L., Miller D.K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
30. Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D.R., Poirier G.G., Salvesen G.S., Dixit V.M. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81:1995;801-809.
31. Hua D.H., Tamura M., Huang X., Stephany H.A., Helfrich B.A., Perchellet E.M., Sperfslage B.J., Perchellet J.P., Jiang S., Kyle D.E., Chiang P.K. Syntheses and bioactivities of substituted 9,10-dihydro-9,10-{1,2}benzenoanthracene-1,4,5,8-tetraones. Unusual reactivities with amines. J. Org. Chem. 67:2002;2907-2912.
32. Marquardt D., McCrone S., Center M.S. Mechanisms of multidrug resistance in HL60 cells: detection of resistance-associated proteins with antibodies against synthetic peptides that correspond to the deduced sequence of P-glycoprotein. Cancer Res. 50:1990;1426-1430.
33. Bellamy W.T. P-Glycoproteins and multidrug resistance. Annu. Rev. Pharmacol. Toxicol. 36:1996;161-183.
34. Lautier D., Canitrot Y., Deeley R.G., Cole S.P.C. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem. Pharmacol. 52:1996;967-977.
35. Krishnamachary N., Center M.S. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res. 53:1993;3658-3661.
36. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., Earnshaw W.C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371:1994;346-347.
37. Wright S.C., Schellenberger U., Wang H., Kinder D.H., Talhouk J.W., Larrick J.W. Activation of CPP32-like proteases is not sufficient to trigger apoptosis: inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity. J. Exp. Med. 186:1997;1107-1117.
38. Komatsu N., Oda T., Muramatsu T. Involvement of both caspase-like proteases and serine proteases in apoptotic cell death induced by ricin, modeccin, diphtheria toxin, and pseudomonas toxin. J. Biochem. 124:1998;1038-1044.
39. Kaufmann S.H. Proteolytic cleavage during chemotherapy-induced apoptosis. Mol. Med. Today. 2:1996;298-303.
40. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15:1999;269-290.